Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-22

Clinical Trial Update: Performance and Impact of the Sepsis ImmunoScore

View source ↗

Summary

Clinical trial update on the Sepsis ImmunoScore study by Prenosis, Inc., which is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Prenosis, Inc. | Conditions: Sepsis | Status: NOT_YET_RECRUITING